Amarin Corp Plc (AMRN)

[ziploc_1]

KM does not intend to talk about fixed dose combos until 2023...QUOTE...(thanks to ggwpg)
"we decided to focus on 1 statin in terms of development....and really go sequential in terms of planning, meaning not take risks to run different phases in parallel because you can do that and save time....
But we are encouraged by the progress we're making. So far, we have made very, very little -- very few public statements because we believe the minute we talk about this, THERE IS COMPETITIVE RISK. But some time in 2023, we will talk not only about the product, what it will bring and the value, but what sort of protection can come with it and so on...

So we are very encouraged with the fixed-dose combination, and it's a significant part of our future fixed-dose combinations in general."

I am betting that the fixed dose combo with statin and MD-2119 makes the most sense.